Risk of ticagrelor versus clopidogrel discontinuation. Response

Rev Esp Cardiol (Engl Ed). 2024 Apr;77(4):356-357. doi: 10.1016/j.rec.2023.11.015. Epub 2024 Jan 12.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Clopidogrel / therapeutic use
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ticagrelor / therapeutic use
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • Ticagrelor
  • Clopidogrel
  • Platelet Aggregation Inhibitors
  • Ticlopidine